Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Non-cash Items (2022 - 2025)

Historic Non-cash Items for Neuroone Medical Technologies (NMTC) over the last 4 years, with Q3 2025 value amounting to $999882.0.

  • Neuroone Medical Technologies' Non-cash Items rose 430767.91% to $999882.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $999882.0, marking a year-over-year increase of 430767.91%. This contributed to the annual value of $999882.0 for FY2025, which is 430767.91% up from last year.
  • Neuroone Medical Technologies' Non-cash Items amounted to $999882.0 in Q3 2025, which was up 430767.91% from $22685.0 recorded in Q3 2024.
  • In the past 5 years, Neuroone Medical Technologies' Non-cash Items ranged from a high of $999882.0 in Q3 2025 and a low of $20064.0 during Q3 2023
  • Moreover, its 4-year median value for Non-cash Items was $55990.0 (2022), whereas its average is $282981.5.
  • In the last 5 years, Neuroone Medical Technologies' Non-cash Items tumbled by 7753.07% in 2023 and then soared by 430767.91% in 2025.
  • Over the past 4 years, Neuroone Medical Technologies' Non-cash Items (Quarter) stood at $89295.0 in 2022, then crashed by 77.53% to $20064.0 in 2023, then grew by 13.06% to $22685.0 in 2024, then soared by 4307.68% to $999882.0 in 2025.
  • Its Non-cash Items was $999882.0 in Q3 2025, compared to $22685.0 in Q3 2024 and $20064.0 in Q3 2023.